Immunoassay of human Neisseria meningitidis serogroup A antibody

Immunological Investigations

Volumn 26, Issue 5-7, 1997, Pages 661-679

  Diakun, K Rittenhouse ^a,b   Martin, D C ^a   Mininni, T ^a   Skuse, J ^a   Ziembiec, N ^a   Quataert, S ^a  

^a PFIZER INC   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; BACTERIUM ANTIBODY; BUFFER; HUMAN SERUM ALBUMIN;

ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FETAL CALF SERUM; HUMAN; HUMAN TISSUE; INCUBATION TIME; NEISSERIA MENINGITIDIS; NORMAL HUMAN; PRIORITY JOURNAL; SEROTYPE; STANDARD; TEMPERATURE SENSITIVITY;

EID: 0030685728     PISSN: 08820139     EISSN: None     Source Type: Journal    
DOI: 10.3109/08820139709088548     Document Type: Article

References (20)

1. Akinwolere, O., D. S. Kumararatne, R. Bartlett, D. M. Goodall, D. Catty. 1994. Enzyme-linked immunosorbent assays for detecting antibodies against meningococcal capsular polysaccharide-A and polysaccharide-C. J. Clini. Path. 47:405-410.
2. Anderson, E. L., T. Bowers, C. M. Mink, D. J. Kennedy, R. B. Belshe, H. Harakeh, L. Pais, P. Holder, G. M. Carlone. 1994. Safety and Immunogenicity of Meningococcal A and C Polysaccharide Conjugate Vaccine in Adults. Infection and Immunity. 62:3391-3395.
3. Beuvery, E. C., F. Miedema, R. van Delft, J. Haverkamp. 1983. Preparation and immunochemical characterization of meningococcal group C polysaccharide-tetanus toxoid conjugates as a new generation of vaccines. Infect. Immun. 40:39-45
4. Carlone, G. M., C. E. Frasch, G. R. Siber, S. Quataert, L. L. Gheesling, S. H. Turner, B. D. Plikaytis, L. O. Helsel, W. E. DeWitt, W. F. Bibb, B. Swaminathan, G. Arakere, C. Thompson, D. Phipps, D. Madore, C. V. Broome. 1991. Multicenter Comparison of Levels of Antibody to the Neisseria meningitidis Group A Capsular Polysaccharide Measured by Using an Enzyme-Linked Immunosorbent Assay. J. of Clinical Microbiology. 30:154-159.
5. Ceesay, S. J., S. J. Allen, A. Menon, J. E. Todd, K. Cham, G. M. Carlone, S. H. Turner, L. L. Gheesling, W. DeWitt, B. D. Plikaytis, B. Greenwood. 1993. Decline in meningococcal antibody levels in African children 5 years after vaccination and the lack of an effect of booster immunization. J. Infect. Dis.. 167:1212-1216.
6. Gheesling, L. L., G. M. Carlone, L. B. Pais, P. F. Holder, S. E. Maslanka, B. D. Plikaytis, M. Achtman, P. Densen, C. E. Frasch, K. Kayhty, J. P. Mays, L. Nencioni, C. Peeters, D. C. Phipps, J. T. Poolman, E. Rosenqvist, G. R. Siber, B. Thiesen, J. Tai, C. M. Thompson, P. P. Vella, J. D. Wenger. 1994. Multicenter comparison of Neisseria-meningilidis serogroup-C anti-capsular polysaccharide antibody-levels measured by a standardized enzyme-linked-immunosorbent-assay. J. Clini. Micro. 32:1475-1482.
7. Harrison, L. H. 1995. The Worldwide Prevention of Meningococcal Infection; Still an Elusive Goal. JAMA. 273:419-421.
8. Hart, C. A., L. E. Cuevas, O. Marzouk, A. P. Thomson, J. Sills. 1993. Management of bacterial meningitis. J. Antimicrob Chemother. 32: Suppl A 49-50.
9. Holder, P. K., S. E. Maslanka, L. B. Pais, J. Dykes, B. D. Plikaytis, G. M. Carlone. 1995. Assignment of Neisseria-meningitidis serogroup-A and serogroup-C class-specific anticapsular antibody concentrations to the new standard reference serum CDC1992. Clin. and Diag. Lab Immunol. 2:132-137.
10. Jackson, L. A., A. Schuchat, M. W. Reeves, J. D. Wenger. 1995. Serogroup C Meningococcal Outbreaks in the United States; An Emerging Threat. JAMA. 273:383-389.
11. Jennings, H. J., A. Gamian, F. E. Ashton. 1987. N-Propionylated Group B Meningococcal Polysacchaide Mimics a Unique Epitope on Group B Neisseria Meningitidis. J. Exp. Med. 165:1207-1211.
12. Jones, D. M. 1993. Current and future trends in immunization against meningitis. J. Antimicrob Chemother. 31:Suppl B 93-9.
13. Madore, D., C. Johnson, D. C. Phipps, Pennridge Pediatrics Assoc., L. A. Popejoy, R. Eby, and D. H. Smith. Safety and Immunologic Response to Haemophilis influenzae Type b Oligosaccharide-CRM197 conjugate vaccine in 1-6 month old infants. Pediatrics 85:331-337.
14. Milagres, L. G., C. E. Melles. 1993. Immune response to anti-meningococcal vaccines. Rev Saude Publica. 27:221-6.
15. Muller, E., M. A. Apicella. 1988. T-Cell Modulation of the Murine Antibody Response to Neisseria meningitidis Group A Capsular Polysaccharide. Infection and Immunity. 56:259-266.
16. Nitta, A. T., J. M. Douglas, G. Arakere, J. B. Ebens. 1993 Disseminated Meningococcal Infection in HIV-Seropositive Patients. Aids. 7:87-90.
17. Pichichero, M., P.Anderson, E. Gotschlich, J. Kamm, A. McMullen, S. Nielsen. 1985. Immunogenicity of O-Acetyl-Negative and-Positive Polysaccharide Vaccines for Infections with Neisseria meningitidis Group C in Infants. J. Infect. Dis. 152:850-851.
18. Romero, J. D., I. Outschoorn. 1993. Selective Biotinylation of Neisseria-Meinigitidis Group-B Capsular Polysaccharide and Application in an Improved ELISA for the Detection of Specific Antibodies. J. Immunol. Meth. 160:35-47.
19. Saliou, P., S. Plotkin. 1994. Vaccination Perspectives. Sante. 4:237-41.
20. Twumasi, P. A., S. Kumah, A. Leach, T. J. D. Odempsey, S. J. Ceesay, J. Todd, C. V. Broome, G. M. Carlone, L. B. Pais, P. K. Holder B. D. Plikaytis, B. M. Greenwood. 1995. A trial of a group-A plus group-C meningococcal polysaccharide-protein conjugate vaccine in African infants. J. Infect. Dis. 171:632-638.